ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 929

Epidemiology of the US National Burden of Pediatric Lupus Hospitalization From 2000-2009

Andrea Knight1, Pamela Weiss2, Knashawn Morales3 and Ron Keren4, 1Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, PA, 4Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Pediatric rheumatology and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Studies indicate that of 11% of adult hospitalizations are related to systemic lupus erythematosus (SLE), with an average charge of $10,000 US per hospitalization and a 1 in 30 chance of death (1). There are few studies describing the hospitalization experience in pediatric SLE, and no national estimates for inpatient healthcare utilization. We aimed to characterize national US trends in inpatient healthcare utilization and mortality associated with pediatric SLE.

Methods: We performed a retrospective, serial, cross-sectional analysis of a nationally representative sample of pediatric SLE patients.  Using the Kids’ Inpatient Database (KID) for years 2000, 2003, 2006 and 2009, we identified patients with SLE by an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code of 710.0 listed as a primary or secondary diagnosis. The main outcome measures were: SLE hospitalization rate, length of stay (LOS), total hospitalization charges and mortality. Patient-specific demographic variables included: age, race, sex and insurance status. Hospital-specific variables included: type (general or children’s), teaching status, location (urban or rural) and region (Northeast, Midwest, South or West). We used KID reported sampling weights to calculate national estimates of the main outcome measures and multivariate regression to evaluate for trends over time.

Results: An estimated 27,076 (SE 1509) pediatric SLE discharges were identified in the KID for the years of study, with a hospitalization rate of 7.9 per 100,000 children (SE 0.5). The median LOS was constant across years at 2 days (IQR 2,3) . The mean total charges per hospitalization (inflated to 2009 USD) were $29,304 for 2000, $36,987 for 2003, $41,664 for 2006 and $42269 for 2009. (p value for trend <0.001). Factors associated with increased total charges were: male sex (p=0.03); age>=18 years (p=0.03); Black race (p=0.02) and Hispanic ethnicity (p=0.003); urban location (p<0.001); and West region (p<0.001). The death rate during hospitalization was 1% for 2000, 1.1% for 2003, 1.2% for 2006 and 0.6% for 2009, which was statistically different across years (p=0.03). Risk factors associated with death were: male sex OR=1.6 (p=0.03), age>=18 years OR=3 (p=0.01); Black race OR=2.6 (p=0.002); other race OR=2.5 (p=0.01); South region OR=2.1 (p=0.006) and West region OR=1.8 (p=0.03).

Conclusion: The length of stay for pediatric SLE has remained stable from 2000 to 2009. Total hospital charges have significantly increased, and mortality has decreased over time, with estimates differing by age, race, sex, hospital location and region. Further studies are needed to investigate the drivers of these differences in healthcare utilization and outcomes.

1.     Krishnan E: Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheumatol 2006, 33(9):1770-1774.


Disclosure:

A. Knight,
None;

P. Weiss,
None;

K. Morales,
None;

R. Keren,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiology-of-the-us-national-burden-of-pediatric-lupus-hospitalization-from-2000-2009/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology